miR-200c下调的纠正通过靶向mlck介导的途径减轻血管内皮细胞诱导的心肌肥厚

IF 5.3 2区医学 Q1 Biochemistry, Genetics and Molecular Biology

Journal of Cellular and Molecular Medicine Pub Date : 2023-07-03 DOI:10.1111/jcmm.17724

引用次数: 0

摘要

在Hu et al.，1发表的文章中包含图4E、F中的错误。图4E中组抑制剂+ PBS的图上传错误。更正后的图4如下所示。作者确认本文的所有结果和结论保持不变。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Correction to Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway

查看原文本刊更多论文

Correction to Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway

In Hu et al.,¹ the published article contains errors in Figure 4E,F. The figure of group inhibitor + PBS in Figure 4E was mis-uploaded. The corrected Figure 4 is below. The authors confirmed that all results and conclusions of this article remain unchanged.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Cellular and Molecular Medicine 医学-细胞生物学

CiteScore

10.00

自引率

1.90%

发文量

496

审稿时长

28 weeks

期刊介绍： Bridging physiology and cellular medicine, and molecular biology and molecular therapeutics, Journal of Cellular and Molecular Medicine publishes basic research that furthers our understanding of the cellular and molecular mechanisms of disease and translational studies that convert this knowledge into therapeutic approaches.